Increased expression of Fcγ receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor α and matrix metalloproteinase
Arjen B. Blom
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorTimothy R. D. J. Radstake
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorAstrid E. M. Holthuysen
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorAnnet W. Slöetjes
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorGerard J. Pesman
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorFred G. J. Sweep
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorFons A. J. van de Loo
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorL. A. B. Joosten
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorPilar Barrera
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorCorresponding Author
Peter L. E. M. van Lent
University Medical Center, Nijmegen, The Netherlands
Department of Rheumatology, University Medical Center St. Radboud, Geert Grooteplein Zuid 26-28, Nijmegen 6500HB, The NetherlandsSearch for more papers by this authorWim B. van den Berg
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorArjen B. Blom
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorTimothy R. D. J. Radstake
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorAstrid E. M. Holthuysen
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorAnnet W. Slöetjes
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorGerard J. Pesman
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorFred G. J. Sweep
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorFons A. J. van de Loo
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorL. A. B. Joosten
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorPilar Barrera
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorCorresponding Author
Peter L. E. M. van Lent
University Medical Center, Nijmegen, The Netherlands
Department of Rheumatology, University Medical Center St. Radboud, Geert Grooteplein Zuid 26-28, Nijmegen 6500HB, The NetherlandsSearch for more papers by this authorWim B. van den Berg
University Medical Center, Nijmegen, The Netherlands
Search for more papers by this authorAbstract
Objective
To evaluate Fcγ receptor (FcγR) expression on synovial macrophages from rheumatoid arthritis (RA) patients and to determine whether this expression correlates with the production of the proinflammatory cytokines tumor necrosis factor α (TNFα), interleukin-1β (IL-1β), IL-12, and matrix metalloproteinase 1 (MMP-1). We also sought to determine whether mature macrophages from RA patients express aberrant levels of FcγRI, FcγRII, and FcγRIII, and to determine the production of inflammatory mediators after immune complex (IC) stimulation.
Methods
Immunohistochemistry was performed on cryostat sections of synovial biopsy specimens obtained from 27 RA patients and 5 controls. FcγR I, II, and III were detected, as well as the proinflammatory mediators IL-1, TNFα, IL-12, and MMP-1. Monocytes were isolated from the blood of 10 RA patients and 10 healthy controls and cultured for 7 days with macrophage colony-stimulating factor to obtain macrophages. Using fluorescence-activated cell sorting, the expression of FcγRI, FcγRII, and FcγRIII was determined. On day 7, macrophages were stimulated with heat-aggregated gamma globulins (HAGGs) for 24 hours. Production of cytokines was measured using enzyme-linked immunosorbent assay, and production of gelatinases/collagenases was measured by degradation of fluorescent gelatin.
Results
Immunohistochemistry showed higher FcγRII and FcγRIII expression in RA synovium than in controls. FcγRII and FcγRIII, but not FcγRI, were highly correlated with the number of synovial macrophages. Consistent with this, TNFα expression correlated positively with FcγRIII expression. Moreover, MMP-1 expression strongly correlated with FcγR I, II, and III expression. Mature macrophages from RA patients showed significantly enhanced expression of FcγRII and FcγRIII compared with controls. Twenty-four hours after stimulation of RA macrophages with HAGGs, significantly higher production of TNFα and gelatinase/collagenase was measured.
Conclusion
RA synovium and mature RA macrophages express significantly elevated levels of FcγRII and FcγRIII, resulting in much higher production of TNFα and gelatinase/collagenase after IC stimulation. These data suggest that disturbed expression of FcγR on mature synovial macrophages is involved in the pathology of RA.
REFERENCES
- 1 Winchester RJ, Agnello V, Kunkel HG. Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis: partial characterization and relationship to lowered complement levels. Clin Exp Immunol 1970; 6: 689–706.
- 2 Cooke TD, Richer S, Hurd E, Jasin HE. Localization of antigen-antibody complexes in intraarticular collagenous tissues. Ann N Y Acad Sci 1975; 256: 10–24.
- 3 Mannik M. Rheumatoid factors in the pathogenesis of rheumatoid arthritis. J Rheumatol Suppl 1992; 32: 46–9.
- 4 Kinne RW, Brauer R, Stuhlmüller B, Palombo-Kinne E, Burmester GR. Macrophages in rheumatoid arthritis. Arthritis Res 2000; 2: 189–202.
- 5 Yanni G, Whelan A, Feighery C, Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis 1994; 53: 39–44.
- 6 Mulherin D, FitzGerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 1996; 39: 115–24.
- 7 Bresnihan B. Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol 1999; 26: 717–9.
- 8 Van Lent PL, van den Hoek AE, van den Bersselaar LA, Spanjaards MF, van Rooijen N, Dijkstra CD, et al. In vivo role of phagocytic synovial lining cells in onset of experimental arthritis. Am J Pathol 1993; 143: 1226–37.
- 9 Van Lent PLEM, Holthuysen AEM, van den Bersselaar LAM, van Rooijen N, Joosten LAB, van de Loo FAJ, et al. Phagocytic lining cells determine local expression of inflammation in type II collagen–induced arthritis. Arthritis Rheum 1996; 39: 1545–55.
- 10 Van Lent PL, Holthuysen AE, van Rooijen N, van de Putte LB, van den Berg WB. Local removal of phagocytic synovial lining cells by clodronate-liposomes decreases cartilage destruction during collagen type II arthritis. Ann Rheum Dis 1998; 57: 408–13.
- 11
Van Lent PL,
van den Bersselaar LA,
Holthuysen AE,
van Rooijen N,
van de Putte LB,
van den Berg WB.
Phagocytic synovial lining cells in experimentally induced chronic arthritis: down-regulation of synovitis by CL2MDP-liposomes.
Rheumatol Int
1994;
13:
221–8.
10.1007/BF00290199 Google Scholar
- 12 Van Meurs JBJ, van Lent PLEM, Holthuysen AEM, Singer II, Bayne EK, van den Berg WB. Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis. Arthritis Rheum 1999; 42: 1128–39.
- 13 Van Meurs J, van Lent P, Holthuysen A, Lambrou D, Bayne E, Singer I, et al. Active matrix metalloproteinases are present in cartilage during immune complex-mediated arthritis: a pivotal role for stromelysin-1 in cartilage destruction. J Immunol 1999; 163: 5633–9.
- 14 Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol 2001; 19: 275–90.
- 15 Dijstelbloem HM, van de Winkel JG, Kallenberg CG. Inflammation in autoimmunity: receptors for IgG revisited. Trends Immunol 2001; 22: 510–6.
- 16 Ravetch JV. Fc receptors. Curr Opin Immunol 1997; 9: 121–5.
- 17 Liu Z, Pudiak D, Looney RJ. Protein tyrosine phosphorylation triggered by human FcγRII. Biochem Biophys Res Commun 1994; 201: 829–34.
- 18 Green JM, Schreiber AD, Brown EJ. Role for a glycan phosphoinositol anchor in Fcγ receptor synergy. J Cell Biol 1997; 139: 1209–17.
- 19 Prins JB, Todd JA, Rodrigues NR, Ghosh S, Hogarth PM, Wicker LS, et al. Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. Science 1993; 260: 695–8.
- 20 Frank MM, Hamburger MI, Lawley TJ, Kimberly RP, Plotz PH. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 1979; 300: 518–23.
- 21 Zuñiga R, Ng S, Peterson MGE, Reveille JD, Baethge BA, Alarcón GS, et al. Low-binding alleles of Fcγ receptor types IIA and IIIA are inherited independently and are associated with systemic lupus erythematosus in Hispanic patients. Arthritis Rheum 2001; 44: 361–7.
- 22 Van Weyenbergh J, Lipinski P, Abadie A, Chabas D, Blank U, Liblau R, et al. Antagonistic action of IFN-β and IFN-γ on high affinity Fcγ receptor expression in healthy controls and multiple sclerosis patients. J Immunol 1998; 161: 1568–74.
- 23 Lobell A, Weissert R, Storch MK, Svanholm C, de Graaf KL, Lassmann H, et al. Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis. J Exp Med 1998; 187: 1543–8.
- 24 Gessner JE, Heiken H, Tamm A, Schmidt RE. The IgG Fc receptor family. Ann Hematol 1998; 76: 231–48.
- 25 Fries LF, Brickman CM, Frank MM. Monocyte receptors for the Fc portion of IgG increase in number in autoimmune hemolytic anemia and other hemolytic states and are decreased by glucocorticoid therapy. J Immunol 1983; 131: 1240–5.
- 26 Salmon JE, Pricop L. Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. Arthritis Rheum 2001; 44: 739–50.
- 27 Blom AB, van Lent PL, Holthuysen AE, van den Berg WB. Immune complexes, but not streptococcal cell walls or zymosan, cause chronic arthritis in mouse strains susceptible for collagen type II auto-immune arthritis. Cytokine 1999; 11: 1046–56.
- 28 Blom AB, van Lent PL, van Vuuren H, Holthuysen AE, Jacobs C, van de Putte LB, et al. FcγR expression on macrophages is related to severity and chronicity of synovial inflammation and cartilage destruction during experimental immune-complex–mediated arthritis (ICA). Arthritis Res 2000; 2: 489–503.
- 29 Wahl SM, Allen JB, Welch GR, Wong HL. Transforming growth factor-β in synovial fluids modulates FcγRIII (CD16) expression on mononuclear phagocytes. J Immunol 1992; 148: 485–90.
- 30 Torsteinsdottir I, Arvidson NG, Hallgren R, Hakansson L. Monocyte activation in rheumatoid arthritis (RA): increased integrin, Fcγ and complement receptor expression and the effect of glucocorticoids. Clin Exp Immunol 1999; 115: 554–60.
- 31 Highton J, Carlisle B, Palmer DG. Changes in the phenotype of monocytes/macrophages and expression of cytokine mRNA in peripheral blood and synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 1995; 102: 541–6.
- 32 Shinohara S, Hirohata S, Inoue T, Ito K. Phenotypic analysis of peripheral blood monocytes isolated from patients with rheumatoid arthritis. J Rheumatol 1992; 19: 211–5.
- 33 Prevoo MLL, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLC. Modified disease activity scores that include twenty-eight–joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44–8.
- 34 Bocanegra TS, McClelland JJ, Germain BF, Espinoza LR. Intraarticular fragmentation of a new Parker-Pearson synovial biopsy needle. J Rheumatol 1980; 7: 248–50.
- 35 Youssef PP, Haynes DR, Triantafillou S, Parker A, Gamble JR, Roberts-Thomson PJ, et al. Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis. Arthritis Rheum 1997; 40: 1400–8.
- 36 Barrera P, Joosten LA, den Broeder AA, van de Putte LB, van Riel PL, van den Berg WB. Effects of treatment with a fully human anti-tumour necrosis factor α monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFα in patients with rheumatoid arthritis. Ann Rheum Dis 2001; 60: 660–9.
- 37 Mairesse N, Ameryckx G, Pierart M, Appelboom T. Effect of aggregated immunoglobulins on mononuclear cell protein production in rheumatoid arthritis. Clin Immunol Immunopathol 1988; 49: 318–25.
- 38 Baeten D, Boots AMH, Steenbakkers PGA, Elewaut D, Bos E, Verheijden GFM, et al. Human cartilage gp-39+,CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum 2000; 43: 1233–43.
- 39 Van Meurs JB, van Lent PL, Joosten LA, van der Kraan PM, van den Berg WB. Quantification of mRNA levels in joint capsule and articular cartilage of the murine knee joint by RT-PCR: kinetics of stromelysin and IL-1 mRNA levels during arthritis. Rheumatol Int 1997; 16: 197–205.
- 40 Grebenschikov N, Geurts-Moespot A, de Witte H, Heuvel J, Leake R, Sweep F, et al. A sensitive and robust assay for urokinase and tissue-type plasminogen activators (uPA and tPA) and their inhibitor type 1 (PAI-1) in breast tumor cytosols. Int J Biol Markers 1997; 12: 6–14.
- 41 Sweep CG, Geurts-Moespot J, Grebenschikov NI, de Witte JH, Heuvel JJ, Schmitt M, et al. External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts. Br J Cancer 1998; 78: 1434–41.
- 42 Benraad TJ, Geurts-Moespot J, Grøndahl-Hansen J, Schmitt M, Heuvel JJ, de Witte JH, et al. Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): report of an EORTC/BIOMED-1 workshop. Eur J Cancer 1996; 32A: 1371–81.
- 43 Drenth JP, van Uum SH, van Deuren M, Pesman GJ, van der Ven-Jongekrijg J, van der Meer JW. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-α and IL-1β production. J Appl Physiol 1995; 79: 1497–503.
- 44 Woesner JF, Nagase H. Protein Profile. Matrix metalloproteinases and TIMPs. New York: Oxford University Press; 2000. p. 109–11.
- 45 Smith JB, Bocchieri MH, Smith JB Jr, Sherbin-Allen L, Abruzzo JL. Colony stimulating factor occurs in both inflammatory and noninflammatory synovial fluids. Rheumatol Int 1990; 10: 131–4.
- 46 Erickson-Miller CL, Brennan JK, Abboud CN. Examination of survival, proliferation and cell surface antigen expression of human monocytes exposed to macrophage colony-stimulating factor (M-CSF). Int J Cell Cloning 1990; 8: 346–56.
- 47 Marsh CB, Pomerantz RP, Parker JM, Winnard AV, Mazzaferri EL Jr, Moldovan N, et al. Regulation of monocyte survival in vitro by deposited IgG: role of macrophage colony-stimulating factor. J Immunol 1999; 162: 6217–25.
- 48 Stohr J, Schindler G, Rothe G, Schmitz G. Enhanced upregulation of the Fcγ receptor IIIa (CD16a) during in vitro differentiation of ApoE4/4 monocytes. Arterioscler Thromb Vasc Biol 1998; 18: 1424–32.
- 49 Alsalameh S, Winter K, Al-Ward R, Wendler J, Kalden JR, Kinne RW. Distribution of TNF-α, TNF-R55 and TNF-R75 in the rheumatoid synovial membrane: TNF receptors are localized preferentially in the lining layer; TNF-α is distributed mainly in the vicinity of TNF receptors in the deeper layers. Scand J Immunol 1999; 49: 278–85.
- 50 Steiner G, Studnicka-Benke A, Witzmann G, Hofler E, Smolen J. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis. J Rheumatol 1995; 22: 406–12.
- 51 Okada Y, Nakanishi I. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (‘gelatinase’) by human neutrophil elastase and cathepsin G. FEBS Lett 1989; 249: 353–6.
- 52 Sorsa T, Konttinen YT, Lindy O, Ritchlin C, Saari H, Suomalainen K, et al. Collagenase in synovitis of rheumatoid arthritis. Semin Arthritis Rheum 1992; 22: 44–53.
- 53 Abrahams VM, Cambridge G, Lydyard PM, Edwards JCW. Induction of tumor necrosis factor α production by adhered human monocytes: a key role for Fcγ receptor type IIIA in rheumatoid arthritis. Arthritis Rheum 2000; 43: 608–16.
- 54 Isakov N. ITIMs and ITAMs: the yin and yang of antigen and Fc receptor-linked signaling machinery. Immunol Res 1997; 16: 85–100.
- 55 Yuasa T, Kubo S, Yoshino T, Ujike A, Matsumura K, Ono M, et al. Deletion of Fcγ receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis. J Exp Med 1999; 189: 187–94.
- 56 Clynes R, Maizes JS, Guinamard R, Ono M, Takai T, Ravetch JV. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J Exp Med 1999; 189: 179–85.
- 57 Barrera P, Blom A, van Lent PLEM, van Bloois L, Beijnen JH, van Rooijen N, et al. Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. Arthritis Rheum 2000; 43: 1951–9.
- 58 Sutterwala FS, Noel GJ, Clynes R, Mosser DM. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med 1997; 185: 1977–85.
- 59 Grazia Cappiello M, Sutterwala FS, Trinchieri G, Mosser DM, Ma X. Suppression of IL-12 transcription in macrophages following Fcγ receptor ligation. J Immunol 2001; 166: 4498–506.
- 60 Van den Berg WB, Bresnihan B. Pathogenesis of joint damage in rheumatoid arthritis: evidence of a dominant role for interleukin-1. Baillieres Best Pract Res Clin Rheumatol 1999; 13: 577–97.
- 61 Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M. Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989; 2: 244–7.
- 62 Joosten LA, Helsen MM, Saxne T, van de Loo FA, Heinegård D, van Den Berg WB. IL-1 α β blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-α blockade only ameliorates joint inflammation. J Immunol 1999; 163: 5049–55.
- 63 Ward PA. Role of complement, chemokines, and regulatory cytokines in acute lung injury. Ann N Y Acad Sci 1996; 796: 104–12.
- 64 Van Lent PL, Nabbe K, Blom AB, Holthuysen AE, Slöetjes A, van de Putte LB, et al. Role of activatory FcγRI and FcγRIII and inhibitory FcγRII in inflammation and cartilage destruction during experimental antigen-induced arthritis. Am J Pathol 2001; 159: 2309–20.
